Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TTHX1114 with DWEK/DSO for Fuchs' Endothelial Dystrophy
NCT04676737Phase 2Completed
- Sponsor
- Trefoil Therapeutics
- Start
- Feb 2021
- Primary completion
- Nov 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of TTHX1114 in Fuchs endothelial dystrophy (FED), sponsored by Trefoil Therapeutics. Started Feb 2021; status: completed.
02
Drugs
TTHX1114
03
Conditions
Fuchs endothelial dystrophy (FED)
Beyond the preview
Go deeper on NCT04676737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04676737.